SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0000950133-09-001026
Filing Date
2009-04-06
Accepted
2009-04-06 17:20:32
Documents
9
Period of Report
2009-05-13

Document Format Files

Seq Description Document Type Size
1 PRE 14A w73474apre14a.htm PRE 14A 381716
2 GRAPHIC w73474aw7347408.gif GRAPHIC 3496
3 GRAPHIC w73474aw7347400.gif GRAPHIC 1380
4 GRAPHIC w73474aw7347402.gif GRAPHIC 5319
5 GRAPHIC w73474aw7347401.gif GRAPHIC 3346
6 GRAPHIC w73474aw7347403.gif GRAPHIC 386
7 GRAPHIC w73474aw7347404.gif GRAPHIC 386
8 GRAPHIC w73474aw7347405.gif GRAPHIC 732
9 GRAPHIC w73474aw7347406.gif GRAPHIC 6206
  Complete submission text file 0000950133-09-001026.txt   413633
Mailing Address 9920 BELWARD CAMPUS DRIVE ROCKVILLE MD 20850
Business Address 9920 BELWARD CAMPUS DRIVE ROCKVILLE MD 20850 240-268-2000
NOVAVAX INC (Filer) CIK: 0001000694 (see all company filings)

IRS No.: 222816046 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 000-26770 | Film No.: 09735775
SIC: 2836 Biological Products, (No Diagnostic Substances)